Trial Profile
Multiple Dose Study in T2DM.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs JNJ 38431055 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 01 Aug 2012 Results published in the Diabetes, Obesity and Metabolism.
- 06 Mar 2010 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 19 Feb 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.